Meeting
2013 ASCO Annual Meeting
A phase I study of MM-121 in combination with multiple anticancer therapies in patients with advanced solid tumors.
Authors
Monica Arnedos
Institut Gustave Roussy, Villejuif, France
Monica Arnedos , Crystal Shereen Denlinger , Wael A. Harb , Olivier Rixe , John Charles Morris , Grace K. Dy , Alex A. Adjei , Joseph Pearlberg , Sarah Follows , Akos Gabor Czibere , Jean-Charles Soria
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics
Sub Track
PI3-Akt-mTOR Pathway
Clinical Trial Registration Number
NCT01447225
Citation
J Clin Oncol 31, 2013 (suppl; abstr 2609)
DOI
10.1200/jco.2013.31.15_suppl.2609
Abstract #
2609
Poster Bd #
10E
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Phase I study of ABT-888 in combination with carboplatin and gemcitabine in subjects with advanced solid tumors.
First Author: Katherine M. Bell-McGuinn
Poster
2014 ASCO Annual Meeting
A phase I and pharmacokinetic study of a weekly dosing schedule of paclitaxel injection concentrate for nano-dispersion (PICN) in patients with advanced solid tumors.
First Author: Wen Wee Ma
Poster
2012 ASCO Annual Meeting
Phase I trial of the polo-like kinase (Plk) inhibitor volasertib (BI 6727) combined with cisplatin or carboplatin in patients with advanced solid tumors.
First Author: Herlinde Dumez
Poster
2023 ASCO Annual Meeting
Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors.
First Author: Chia-Chi Lin